Precision Business Insights
Portfolio

 

Aortic Repair Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

The Aortic Repair Market: By Indication (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm), Site (Infrarenal and Pararenal ), Anatomy (Traditional, Complex), and By Product (Percutaneous EVAR, Fenestrated EVAR, Aortic Stents, TAA Grafts), By End Users (Hospitals, Clinics, Diagnostic Centres, Ambulatory Surgical Centres) By Geography

 

Aortic Repair Market

 

Market Outline: Aortic Repair Market

Irregular extension of aorta in the abdomen of a person is an ordinarily happening aneurysm on the planet. People of any age are helpless the frequency of a stomach aortic aneurysm. Agony emerging from such aneurysm can prompt loss of motion or even reason passing of the patient through cardiovascular issue, for example, blood vessel stenosis. Endovascular aneurysm repair (EVAR) is an aggregate term for all medications that are coordinated to carefully fix the aortic aneurysm situated in patient’s stomach area.

 

Market Dynamics: Aortic Repair Market 

The effect of drivers is currently moderate, however is relied upon to increment in future and drive the aortic repair, inferable from high predominance of stomach aortic aneurysm infection and development in geriatric populace. The effect of limitations is foreseen to diminish amid the figure time frame as government is taking strong endeavors toward change of cost structure of aortic repair devices and treatment techniques. Besides, government is taking activities to expand mindfulness identified with accessibility of aortic repair treatment strategies and gadgets.

 

Market Scope: Aortic Repair Market 

The Aortic Repair Market is classified on the basis of Indication, anatomy, product, end user and geographical regions.

Based on Indication, Aortic Repair market is segmented as

  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic Aneurysm

Based on Site, Aortic Repair market is segmented as

  • Infrarenal
  • Pararenal

Based on Anatomy, Aortic Repair market is segmented as

  • Traditional
  • Complex

Based on Product , Aortic Repair market is segmented as

  • Percutaneous EVAR
  • Fenestrated EVAR
  • Aortic Stents
  • TAA Grafts

Based on End User, Aortic Repair market is segmented as

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Ambulatory Surgical Centres

Geography

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Market Summary: Aortic Repair Market 

Key players in the aortic repair market have propelled different new products for aortic repair treatment and this has emphatically influenced the development of the aortic repair market. For example, in 2017, Lombard Medical Inc. received approval from the Japanese Ministry of Health, Labor and Welfare for its new IntelliFlex Low Profile (LP) Delivery System for the Aorfix Endovascular Stent Graft. In 2016, Lombard Medical, Inc. received CE Mark approval for its IntelliFlex Low Profile (LP) Delivery System for the Aorfix Endovascular Stent Graft. In 2013, Lombard Medical Inc. propelled its Aorfix, a most recent endovascular stent join in the U.S. showcase. In 2014, Cordis Corporation ( Cardinal Health, Inc.) propelled its INCRAFT AAA Stent Graft System (INCRAFT System), a device for use amid endovascular aneurysm repair (EVAR) for patients experiencing infrarenal AAA. In 2015, Endologix, Inc. gotten endorsement from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its AFX Endovascular AAA System for the treatment of stomach aortic aneurysms. In 2014, Medtronic Plc. gotten endorsement for its new Endurant IIs in the U.S. Furthermore, Europe. Endurant IIs is a most recent stent unite framework for the endovascular repair of aortic aneurysms. These approvals have prompted advancement of novel items in the market, which is relied upon to drive the development of worldwide stomach aortic aneurysm repair gadgets advertise sooner rather than later. Expanding coordinated efforts and securing exercises by key players in the market is likewise anticipated that would bolster development of worldwide aortic repair market.

 

Regional Analysis: Aortic Repair Market 

Geographically Aortic Repair Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe North America is relied upon to hold a prevailing position in the worldwide aortic repair market, attributable to nearness of top players and successive launch of novel products. For example, in 2015, Cook Group Incorporated launched its most recent Zenith Alpha stomach endovascular unit in Canada. Apex Alpha stomach is demonstrated for endovascular treatment of patients with stomach aortic aneurysm. The Asia Pacific is additionally anticipated that would show high development in the worldwide aortic repair market, inferable from expanding endorsements of novel gadgets by major administrative bodies in the area. For example, in Lombard Medical, Inc. gotten endorsement for its new AorFlex conveyance framework from the Japanese Ministry of Health, Labor and Welfare. AorFlex is a conveyance framework for Aorfix endovascular stent unite demonstrated for the treatment of aortic repair.

 

Market participants: Aortic Repair Market 

Some of the players in Aortic Repair Market

  • Medtronic (U.S.)
  • Edwards Lifesciences (U.S.)
  • Sorin Group (Italy)
  • Abbott Laboratories (U.S.),
  • Admedes Schuessler GmbH (Germany)
  • Accellent Inc. (U.S.)
  • AorTech International (U.K.)
  • Arbor Surgical Technologies, Inc. (U.S.)
  • Boston Scientific (U.S.)
  • CryoLife, Inc. (U.S.)
  • AutoTissue GmbH (Germany)
  • Micro Interventional Devices, Inc. (U.S.)
  • Neovasc, Inc. (Canada)
  • Colibri Heart Valve, LLC (U.S.)
  • Leman Cardiovascular Sa (Switzerland)
  • JenaValve Technology (Germany)
  • MiCardia Corporation (U.S.)
  • On-X Life Technologies, Inc. (U.S.)